반응식
[C:1]([C:4]1[CH:9]=[CH:8][C:7]([C:10]2[N:11]=[C:12]([N:16]3[CH2:21][CH2:20][N:19]([C:22](O)=O)[CH2:18][CH2:17]3)[S:13][C:14]=2[CH3:15])=[CH:6][CH:5]=1)([OH:3])=[O:2].CC(O)=O.C(O[Na])(C)=O.C=O.[BH3-]C#N.[Na+]>Cl.O1CCOCC1>[CH3:15][C:14]1[S:13][C:12]([N:16]2[CH2:17][CH2:18][N:19]([CH3:22])[CH2:20][CH2:21]2)=[N:11][C:10]=1[C:7]1[CH:8]=[CH:9][C:4]([C:1]([OH:3])=[O:2])=[CH:5][CH:6]=1참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
4-[4-(4-Carboxyphenyl)-5-methylthiazol-2-yl]-piperazine-1-carboxylic acid tort-butyl ester (0.421 mmol) was dissolved in 4M HCl in 1,4-dioxane, and stirred at room temperature for 1 h. The solvent was then removed in vacuo, and the residue 4-(5-methyl-2-piperazin-1-yl-thiazol-4-yl)-benzoic acid was suspended in methanol (10 mL) and treated with AcOH/AcONa buffer (pH ˜5.5, 5 mL), and formaldehyde (0.547 mmol). The reaction mixture was stirred at room temperature for 1 h, then treated with NaCNBH3 (0.547 mmol) and stirred at room temperature overnight. The solvent was then removed under vacuum, and the residue was purified by column chromatography to afford the title compound (0.403 mmol, 95%).
후처리
- customThe solvent was then removed in vacuo
- stirringThe reaction mixture was stirred at room temperature for 1 h
- stirringstirred at room temperature overnight
- customThe solvent was then removed under vacuum
- customthe residue was purified by column chromatography
출처 및 근거
- ORD 기록
- ord-cfdb7a612b9f4699bda65f09077a0aa7
- 출처 데이터셋
- uspto-grants-2012_06
- 특허 번호
- US08198283B2
연결된 노트
불러오는 중…